News

The share price of Uranium Energy Corp. (NYSEAMERICAN:UEC) surged by 22.62% on May 23, 2025. Let’s shed some light on the ...
India’s mining sector is set for long-term growth despite early 2025 volatility driven by US-China tariff tensions, according ...
Applied Digital has a huge growth opportunity with the explosion in demand for data centers. IonQ is a pioneer in the ...
The S&P 500 is making its way back up from a tariff-included plummet, but not all of its stocks are doing as well. Amazon ( ...
Tempus AI, Inc. is revolutionizing healthcare genomics with AI and data partnerships. Click here to read an analysis on TEM ...
Given how fast things are changing on Wall Street and in Washington, it may seem strange to consider investments that will be part of your portfolio for the next 10 years. But believe it or ...
Growth stocks can be exciting. However, intelligent investors understand that big winners don't just come from fast growth, but through a combination of growth at a cheap price. Many investors ...
Stocks have been on a wild ride lately. The S&P 500 ETF ( SPY) is now sitting exactly 20% above its April lows. I say ...
Palantir stock has been on a tear in 2025, rising more than 40% even after Tuesday's big drop. Analysts have expressed concerns about the AI firm's valuation.
Enova’s 600% stock surge, strong execution, and growing moat outweigh regulatory risks for investors focused on performance.
The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.